Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.525 USD | -6.52% | -14.56% | +38.60% |
May. 15 | Solid Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.60% | 345M | |
+7.93% | 115B | |
+13.06% | 107B | |
-12.89% | 22.31B | |
-3.99% | 21.6B | |
-6.20% | 18.23B | |
-39.93% | 17.62B | |
+6.97% | 14.26B | |
+32.66% | 12.37B | |
-28.39% | 8.28B |
- Stock Market
- Equities
- SLDB Stock
- News Solid Biosciences Inc.
- Solid Biosciences New Drug Application for Duchenne Muscular Dystrophy Gets FDA Clearance; Shares Surge After Hours